Chemoinformaics analysis of 5-Propyltridecane
Molecular Weight | 226.448 | nRot | 12 |
Heavy Atom Molecular Weight | 192.176 | nRig | 3 |
Exact Molecular Weight | 226.266 | nRing | 0 |
Solubility: LogS | -4.162 | nHRing | 0 |
Solubility: LogP | 4.715 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 49.391 |
nHD | 0 | BPOL | 34.109 |
QED | 0.494 |
Synth | 2.594 |
Natural Product Likeliness | 1.983 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.673 |
Pgp-sub | 0.005 |
HIA | 0.004 |
CACO-2 | -4.422 |
MDCK | 0.0000237 |
BBB | 0.233 |
PPB | 0.922475 |
VDSS | 3.731 |
FU | 0.0600831 |
CYP1A2-inh | 0.966 |
CYP1A2-sub | 0.123 |
CYP2c19-inh | 0.58 |
CYP2c19-sub | 0.458 |
CYP2c9-inh | 0.257 |
CYP2c9-sub | 0.642 |
CYP2d6-inh | 0.111 |
CYP2d6-sub | 0.105 |
CYP3a4-inh | 0.14 |
CYP3a4-sub | 0.251 |
CL | 16.276 |
T12 | 0.587 |
hERG | 0.018 |
Ames | 0.005 |
ROA | 0.022 |
SkinSen | 0.93 |
Carcinogencity | 0.274 |
EI | 0.932 |
Respiratory | 0.162 |
NR-Aromatase | 0.01 |
Antiviral | Yes |
Prediction | 0.69813 |